drugset / Trial / NCT02048098

Misoprostol for Second Trimester Termination of Pregnancy

NCT02048098

Phase 3 Completed 130 enrolled Ataturk University
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to compare the efficacy of 400 µg vaginal misoprostol per 3 hours to 400 µg buccal misoprostol per 3 hours in second trimester termination of viable pregnancy

Timeline

Start
2014-01
Primary completion
2014-12
Completion
2014-12

Drugs

EvaluationDrugModalityDoseRoute
Comparator Misoprostol Other / unclassified 400 ug Intrathecal

Indications

No indication recorded.